Tim McCarthy, CEO of ImmuPharma, talks to Proactive Investor on the successful £3.55m fundraising, giving validation of new corporate strategy from Lupuzor™ partner Avion Pharmaceuticals
This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy
